Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

V. Roy, A. K. Stewart, P. L. Bergsagel, A. Dispenzieri, K. Laumann, J. Allred, M. Q. Lacy, R. Fonseca, C. B. Reeder, S. Kumar, C. E. Rivera, M. A. Gertz, F. K. Buadi, S. R. Hayman, S. V. Rajkumar

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation'. Together they form a unique fingerprint.